References of Pain Manegement

References

1. Fields HL. Pain. New York: McGraw-Hill; 1987:364.

2. Heller PH et al. Peripheral neural contributions to inflammation. In: Fields HL et al., eds. Pharmacological Approach to the Treatment of Chronic Pain. Progress in Pain Research and Management. Seattle: IASP Press; 1994:31.

3. Dickenson AH. The roles of transmitters and their receptors in systems related to pain and analgesia. In: Max M, ed. Pain 1999: an updated review. Seattle: IASP Press; 1999:381.

4. Wilcox GL. Pharmacology of pain and analgesia. In: Max M, ed. Pain 1999: an updated review. Seattle: IASP Press; 1999:573.

5. Dickenson AH et al. Mechanisms of chronic pain and the developing nervous system. In: McGrath PJ et al., eds. Chronic and Recurrent Pain in Children and Adolescents. Progress in Pain Research and Management. Seattle: IASP Press; 1999:5.

6. Besson JM. The neurobiology of pain. Lancet. 1999;353:1610.

7. Golianu B et al. Pediatric acute pain management. Pediatr Clin N Am 2000;47:559.

8. McCaffery M et al. Pain: Clinical Manual. St. Louis: Mosby; 1999:15.

9. Woolf CJ et al. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959.

10. McMahon SB et al. Silent afferents and visceral pain. In: Fields H et al., eds. Pharmacological Approach to the Treatment of Chronic Pain. Progress in Pain Research and Management. Seattle: IASP Press; 1994:11.

11. Willis WD Jr. Introduction to the basic science of pain and headache for the clinician: physiological concepts. In: Max M, ed. Pain 1999: an updated review. Seattle: IASP Press; 1999:561.

12. Price DP et al. Central neural mechanisms of normal and abnormal pain state. In: Fields HL et al., eds. Pharmacological Approach to the Treatment of Chronic Pain. Progress in Pain Research and Management. Seattle: IASP Press; 1994:61.

13. Dickenson AH. NMDA receptor antagonists as analgesics. In: Fields HL et al., eds. Pharmacological Approach to the Treatment of Chronic Pain. Progress in Pain Research and Management. Seattle: IASP Press; 1994:173.

14. Pini LA et al. Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid. Pharmacology 1997;54:84.

15. Sandrini M et al. Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes. Pharmacology 2002;65:1937.

16. Dickenson AH. Where and how do opioids act? Proceedings of the 7th World Congress on Pain. Progress in Pain Research and Management 1994;2:525.

17. Clinical Practice Guideline, Cancer Pain Management. U.S. Department of Health and Human Services, Agency for Health Care Policy and Research. AHCPR Pub. Rockville, MD; 1994.

18. Porternoy RK. Opioids and adjuvant analgesics. In: Max M, ed. Pain 1999: an updated review. Seattle: IASP Press; 1999:3.

19. Max MB et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250.

20. Beaver WT et al. Comparison of the analgesic effects of morphine, hydroxyzine, and their combination in patients with postoperative pain. In: Bonica JJ et al., eds. Advances in Pain Research and Therapy. New York: Raven Press; 1976:553.

21. American Pain Society. Principles of analgesic use in the treatment of acute and chronic cancer pain. 2nd ed. Clin Pharm 1990;9:601.

P.8p34

22. LoVecchio F et al. The use of analgesics in patients with acute abdominal pain. J Emerg Med 1997;15:775.

23. Pace S et al. Intravenous morphine for early pain relief in patients with acute abdominal pain. Acad Emerg Med 1996;3:1086.

24. Clinical Practice Guideline, Acute Pain Management. U.S. Department of Health and Human Services, Agency for Health Care Policy and Research. AHCPR Pub. No. 92-0032. Rockville, MD; 1992.

25. Krames ES. Intrathecal infusional therapies for intractable pain: patient management guidelines. J Pain Symptom Manage 1993;8:36.

26. Skevington SM. The relationship between pain and depression: a longitudinal study of early synovitis. Proceedings of the 7th World Congress on Pain. Progress in Pain Research and Management 1994;2:201.

27. Gureje O et al. Persistent pain and well-being: a World Health Organization study in primary care. JAMA 1998;280:147.

28. Ashburn MA et al. Management of chronic pain. Lancet 1999;353:1865.

29. Rowbotham MC et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003 Mar 27;348:1223.

30. Weissman DE. Doctors, opioids, and the law: the effect of controlled substances regulations on cancer pain management. Semin Oncol 1993;20(2 Suppl 1):53.

31. Hill CS Jr. The barriers to adequate pain management with opioid analgesics. Semin Oncol 1993;20(2 Suppl 1):1.

32. Weinstein SM et al. Physicians' attitudes toward pain and the use of opioid analgesics: results of a survey from the Texas Cancer Pain Initiative. South Med J 2000;93:479.

33. Sloan PA et al. Cancer pain assessment and management by housestaff. Pain 1996;67:475.

34. Foley KM. The treatment of cancer pain. N Engl J Med 1985;313:84.

34a. World Health Organization. Cancer pain relief and palliative care. Report of a WHO expert committee [World Health Organization Technical Report Series, 804]. Geneva, Switzerland: World Health Organization; 1990.

35. World Health Organization guidelines at http://www.who.int/cancer/palliative/painladder/en/.

36. Fishbain et al. Genetic testing for enzymes of drug metabolism: does it have clinical utility for pain medicine at the present time? A structured review. Pain Med 2004;5:81.

37. Stamer UM et al. Genetics and variability in opioid response. Eur J Pain 2005;101.

38. Claiborne R. A patient looks at pain and analgesia. Hosp Pract 1982;17:21.

39. Donovan BD. Patient attitudes to postoperative pain relief. Anesthesia and Intensive Care 1983;11:125.

40. Cooper SA et al. Comparative analgesic potency of aspirin and ibuprofen. J Oral Surg 1977;35:898.

41. Winter L Jr et al. Analgesic activity of ibuprofen (Motrin) in postoperative oral surgical pain. Oral Surg Oral Med Oral Pathol 1978;45:159.

42. Heidrich G et al. Efficacy and quality of ibuprofen and acetaminophen plus codeine analgesia. Pain 1985;22:385.

43. Indelicato PA et al. Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clin Ther 1986;8:269.

44. Lasagna L. Analgesic methodology: a brief history and commentary. J Clin Pharmacol 1980;20(Pt. 2):373.

45. Levine J et al. Relationship of duration of analgesia to opioid pharmacokinetic variables. Brain Res 1983;289:391.

46. Hammack JE et al. Use of orally administered opioids for cancer-related pain. Mayo Clin Proc 1994;69:384.

47. Davis T et al. Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer. Hospice 1993;9:85.

48. Crews JC et al. Clinical efficacy of methadone in patients refractory to other mu-opioid receptor agonist analgesics for management of terminal cancer pain. Case presentations and discussion of incomplete cross-tolerance among opioid agonist analgesics. Cancer 1993;72:2266.

49. Miller RR. Propoxyphene: a review. Am J Hosp Pharm 1977;34:413.

50. Li Wan Po A et al. Systematic overview of co-proxamol to assess analgesic effects in addition of dextropropoxyphene to paracetamol. BMJ 1997;315:1565.

51. Beaver WT. Analgesic efficacy of dextropropoxyphene and dextropropoxyphene-containing combinations: a review. Human Toxicology 1984;3(Suppl):191S.

52. Almirall J et al. Propoxyphene-induced hypoglycemia in a patient with chronic renal failure. Nephron 1989;53:273.

53. Savage SR. Chronic pain and the disease of addiction: the interfacing roles of pain medicine and addiction medicine. In: Max M, ed. Pain 1999: an updated review. Seattle: IASP Press; 1999:115.

54. Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of critical issues. J Pain Symptom Manage 1996;11:203.

55. Lewis JH. Hepatic toxicity of nonsteroidal anti-inflammatory drugs. Clin Pharm 1984;3:128.

56. Seeff LB et al. Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med 1986;104:399.

57. Baldo BA et al. Chemistry of drug allergenicity. Curr Opin Allergy Clin Immunol 2001;1:327.

58. Longo WE et al. Prokinetic agents for lower gastrointestinal motility disorders. Dis Colon Rectum 1993;36:696.

59. Laizure SC. Considerations in morphine therapy. Am J Hosp Pharm 1994;51:2042.

60. Chun-Su Y et al. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA 2000;283:367.

61. Clark RF. Meperidine: therapeutic use and toxicity. J Emerg Med 1995;13:797.

62. Catapano MS. The analgesic efficacy of ketorolac for acute pain. J Emerg Med 1996;14:67.

63. Neighbor ML et al. Intramuscular ketorolac vs oral ibuprofen in emergency department patients with acute pain. Acad Emerg Med 1998;5:118.

64. Tramer MR et al. Comparing analgesic efficacy of non-steroidal antiinflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review. Acta Anaesthesiol Scand 1998;42:71.

65. Chaiamnuay S et al. Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs. Am J Health Syst Pharm 2006;63:1837.

66. Hallen H et al. The nasal reactivity in patients with nasal polyps. ORL J Otorhinolaryngol Relat Spec 1994;56:276.

67. Muther RS et al. Aspirin-induced depression of glomerular filtration rate in normal humans: role of sodium balance. Ann Intern Med 1981;94:317.

68. Schoch PH et al. Acute renal failure in an elderly woman following intramuscular ketorolac administration. Ann Pharmacother 1992;26:1233.

69. Pearce CJ et al. Renal failure and hyperkalemia associated with ketorolac tromethamine. Arch Intern Med 1993;153:1000.

70. Epstein M. Renal prostaglandins and the control of renal function in liver disease. Am J Med 1986;80(Suppl 1A):46.

71. Zipser RD et al. Implication of nonsteroidal anti-inflammatory drug therapy. Am J Med 1986;80(Suppl 1A):78.

72. Brater DC. Drug–drug and drug-disease interactions with nonsteroidal anti-inflammatory drugs. Am J Med 1986;80(Suppl 1A):62.

73. Dunn MJ et al. Renal effects of drugs that inhibit prostaglandin synthesis. Kidney Int 1980;18:609.

74. Blackshear JL et al. NSAID-induced nephrotoxicity, avoidance, detection and treatment. Drug Ther Hosp 1983;(Nov.):47.

75. Zipser RD et al. Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab 1979;48:895.

76. Donker AJ et al. The effect of indomethacin on kidney function and plasma renin activity in man. Nephron 1976;17:288.

77. Walsche JJ et al. Acute oliguric renal failure induced by indomethacin. Possible mechanism. Ann Intern Med 1979;91:47.

78. Favre L et al. Reversible renal failure from combined triamterene and indomethacin. Ann Intern Med 1982;96:317.

79. Stillman MT et al. Adverse effects of nonsteroidal anti-inflammatory drugs on the kidney. Med Clin North Am 1982;68:371.

80. Finkelstein A et al. Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis. A possible T-lymphocyte disorder. Am J Med 1982;72:81.

81. Fung DL et al. A comparison of alphaprodine and meperidine pharmacokinetics. J Clin Pharmacol 1980;20:37.

82. Poniatowski BC. Continuous subcutaneous infusions for pain control. Journal of Intravenous Nursing 1991;14:30.

83. Lang AH et al. Treatment of severe cancer pain by continuous infusion of subcutaneous opioids. Recent Results Cancer Res 1991;121:51.

84. Sawaki Y et al. Patient and nurse evaluation of patient-controlled analgesia delivery systems for postoperative pain management. J Pain Symptom Manage 1992;7:443.

85. Shaffer HJ et al. Patterns of substance use among methadone maintenance patients. Indicators of outcome. J Subst Abuse Treat 1992;9:143.

86. Gossop M et al. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict 1992;87:1527.

87. Hoffman M et al. Pain management in the opioid-addicted patient with cancer. Cancer 1991;68:1121.

88. Rickford WJ et al. Epidural analgesia in labour and maternal posture. Anaesthesia 1983;38:1169.

89. Conacher ID et al. Epidural analgesia following thoracic surgery. A review of two years' experience. Anaesthesia 1983;38:546.

90. Adu-Gymafi Y et al. High dose epidural morphine for surgical analgesia. Middle East J Anaesthesiol 1985;8:165.

91. Haynes SR et al. Comparison of epidural methadone with epidural diamorphine for analgesia following caesarean section. Acta Anaesthesiol Scand 1993;37:375.

92. Jacobson L et al. Intrathecal methadone: a dose-response study and comparison with intrathecal morphine 0.5 mg. Pain 1990;43:141.

93. Krames ES. Intrathecal infusional therapies for intractable pain: patient management guidelines. J Pain Symptom Manage 1993;8:36.

94. Uhde TW et al. Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study. Psychiatry Res 1980;2:37.

95. Bond WS. Psychiatric indications for clonidine: the neuropharmacologic and clinical basis. J Clin Psychopharmacol 1986;6:81.

96. Gold MS et al. Opiate withdrawal using clonidine. A safe, effective and rapid non-opiate treatment. JAMA 1980;243:343.

97. MacGregor TR et al. Pharmacokinetics of transdermally delivered clonidine. Clin Pharmacol Ther 1985;38:278.

98. Arndts D et al. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine. Eur J Clin Pharmacol 1984;26:78.

99. Clark HW et al. Clonidine transdermal patches: a recovery oriented treatment of opiate withdrawal. California Society for the Treatment of Alcohol Other Drug Dependency News 1986;13:1.

100. Kanto J et al. Obstetric analgesia: pharmacokinetics and its relation to neonatal behavioral and adaptive functions. Biological Research in Pregnancy and Perinatology 1984;5:23.

101. Mirkin BL. Perinatal pharmacology: placental transfer, fetal localization, and neonatal disposition of drugs. Anesthesiology 1975;43:156.

P.8p35

102. Nation RL. Drug kinetics in childbirth. Clin Pharmacokinet 1980;5:340.

103. Jepson HA et al. The Apgar score: evolution, limitations, and scoring guidelines. Birth 1991;18:83.

104. Bardy AH et al. Objectively measured perinatal exposure to meperidine and benzodiazepines in Finland. Clin Pharmacol Ther 1994;55:471.

105. Nimmo WS et al. Narcotic analgesics and delayed gastric emptying during labour. Lancet 1975; 1:890.

106. Refstad SO et al. Ventilatory depressions of the newborn of women receiving pethidine or pentazocine. Br J Anaesth 1980;52:265.

107. Atkinson BD et al. Double-blind comparison of intravenous butorphanol (Stadol) and fentanyl (Sublimaze) for analgesia during labor. Am J Obstet Gynecol 1994;171:993.

108. Isenor L et al. Intravenous meperidine infusion for obstetric analgesia. J Obstet Gynecol Neonatal Nurs 1993;22:349.

109. Rosaeg OP et al. Maternal and fetal effects of intravenous patient-controlled fentanyl analgesia during labour in a thrombocytopenic patient. Can J Anaesth 1992;39:277.

110. Galloway FM et al. Comparison of analgesia by intravenous butorphanol and meperidine in patients with post-operative pain. Can Anaesth Soc J 1977;24:90.

111. Ameer B et al. Drug therapy reviews: evaluation of butorphanol tartrate. Am J Hosp Pharm 1979;36:1683.

112. Sprigge JS et al. Nalbuphine versus meperidine for post-operative analgesia: a double-blind comparison using the patient controlled analgesic technique. Canadian Anaesthesiology Society Journal 1983;30:517.

113. Young RE. Double-blind placebo controlled oral analgesic comparison of butorphanol and pentazocine in patients with moderate to severe post-operative pain. J Int Med Res 1977;5:422.

114. Dayer P et al. The pharmacology of tramadol. Drugs 1994;47(Suppl 1):3.

115. Lee CR et al. Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 1993;46:313.

116. Stubhaug A et al. Lack of analgesic effect of 50 and 100 mg oral tramadol after orthopaedic surgery: a randomized, double-blind, placebo and standard active drug comparison. Pain 1995;62:111.

117. Moore PA et al. Tramadol hydrochloride: analgesic efficacy compared with codeine, aspirin with codeine, and placebo after dental extraction. J Clin Pharmacol 1998;38:554.

118. Ortho-McNeil Pharmaceuticals, Inc. Ultram package insert. Raritan, NJ: April, 1998.

119. Spiller HA et al. Prospective multicenter evaluation of tramadol exposure. J Toxicol 1997; 35:361.

120. Tobias JD. Seizures after tramadol overdose. South Med J 1997;90:826.

121. Portenoy RK et al. Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics. Anesthesiology 1993;78:36.

122. Payne R. Transdermal fentanyl: suggested recommendations for clinical use. J Pain Symptom Manage 1992;7(3 Suppl):S40.

123. Calis KA et al. Transdermally administered fentanyl for pain management. Clin Pharm 1992;11:22.

124. Rose PG et al. Fentanyl transdermal system overdose secondary to cutaneous hyperthermia. Anesth Analg 1993;77:390.

125. DeSio JM et al. Intravenous abuse of transdermal fentanyl therapy in a chronic pain patient. Anesthesiology 1993;79:1139.

126. Lichtor JL et al. The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain. Anesth Analg 1999;89:732.

127. Cephalon Incorporated. Fentora package insert. Salt Lake City, UT: Jun, 2006.

128. Cohen FL. Postsurgical pain relief: patients' status and nurses' medication choices. Pain 1980;9:265.

129. Morland TJ et al. Doxepin in the prophylactic treatment of mixed ‘vascular’ and tension headache. Headache 1979;19:382.

130. Westerling D et al. Absorption and bioavailability of rectally administered morphine in women. Eur J Clin Pharmacol 1982;23:59.

131. Westerling D. Rectally administered morphine: plasma concentration in children premedicated with morphine in hydrogel and in solution. Acta Anaesthesiol Scand 1985;29:653.

132. Babul N et al. Pharmacokinetics of two novel rectal controlled-release morphine formulations. J Pain Symptom Manage 1992;7:400.

133. Wilkinson TJ et al. Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients. Cancer Chemother Pharmacol 1992;31:251.

134. Feinmann C. Pain relief by antidepressants: possible modes of action. Pain 1985;23:1.

135. Kocher R. The use of psychotropic drugs in the treatment of chronic, severe pain. Eur Neurol 1976;14:458.

136. Ward NG et al. The effectiveness of tricyclic antidepressants in the treatment of coexisting pain and depression. Pain 1979;7:331.

137. Adler RH. Psychotropic agents in the management of chronic pain. Journal of Human Stress 1978;4:15.

138. Urban BJ et al. Long-term use of narcotic/ antidepressant medication in the management of phantom limb pain. Pain 1986;24:191.

139. Fainsinger R et al. Methadone in the management of cancer pain: a review. Pain 1993;52:137.

140. Fainsinger R et al. Methadone in the management of cancer pain: a review. Pain 1993;52:137.

141. Berkowitz BA. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone. Clin Pharmacokinet 1976;1:219.

142. Symonds P. Methadone and the elderly. BMJ 1977;1:512.

143. Gourlay GK et al. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 1986;25:297.

144. Miser AW et al. Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediatr 1980;96:930.

145. Church JJ. Continuous narcotic infusions for relief of postoperative pain. BMJ 1979;1:977.

146. Hupert C et al. Effect of hydroxyzine on morphine analgesia for the treatment of postoperative pain. Anesth Analg 1980;59:690.

147. Stambaugh JE Jr et al. Analgesic efficacy and pharmacokinetic evaluation of meperidine and hydroxyzine, alone and in combination. Cancer Invest 1983;1:111.

148. Rumore MM et al. Clinical efficacy of antihistaminics as analgesics. Pain 1986;25:7.

149. Rumore MM et al. Analgesic effects of antihistaminics. Life Sci 1985;36:403.

150. Vecht CJ. Clinical Management of brain metastasis. J Neurol 1998;245:127.

151. Campa JA 3rd et al. The management of intractable bone pain: a clinician's perspective. Semin Nucl Med 1992;22:3.

152. Miller LJ et al. Pain management with intravenous ketorolac. Ann Pharmacother 1993;27:307.

153. Terman GW et al. A case of opiate-insensitive pain: malignant treatment of benign pain. Clin J Pain 1992;8:255.

154. Goldman B. Use and abuse of opioid analgesics in chronic pain. Can Fam Physician 1993;39:571.

155. Bowsher D. Pain syndromes and their treatment. Curr Opin Neurol Neurosurg 1993;6:257.

156. Mercadante S et al. Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manage 2003;26:769.

157. Sjögren P et al. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 1993;55:93.

158. Romac DR. Safety of prolonged, high-dose infusion of naloxone hydrochloride for severe methadone overdose. Clin Pharm 1986;5:251.

159. Lewis JM et al. Continuous naloxone infusion in pediatric narcotic overdose. Am J Dis Child 1984;138:944.

160. Wang DS et al. Nalmefene: a long-acting opioid antagonist. Clinical implications in emergency medicine. J Emerg Med 1998;16:471.

161. Kaplan JL et al. Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose. Ann Emerg Med 1999;34:42.

162. Quan DB et al. Clonidine in pain management. Ann Pharmacother 1993;27:313.

163. Sullivan MJ et al. The treatment of depression in chronic low back pain: review and recommendations. Pain 1992;50:5.

164. Herr KA et al. Depression and the experience of chronic back pain: a study of related variables and age differences. Clin J Pain 1993;9:104.

165. Gonzales GR. Postherpes simplex type 1 neuralgia simulating postherpetic neuralgia. J Pain Symptom Manage 1992;7:320.

166. Max MB et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250.

167. Penfold J et al. Pain syndromes in HIV infection. Can J Anaesth 1992;39:724.

168. Kerrick JM et al. Low-dose amitriptyline as an adjunct to opioids for postoperative orthopedic pain: a placebo-controlled trial. Pain 1993;52:325.

169. Dillin W et al. Analysis of medications used in the treatment of cervical disk degeneration. Orthop Clin North Am 1992;23:421.

170. Onghena P et al. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992;49:205.

171. Max MB et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250.

172. Acton J et al. Amitriptyline produces analgesia in the formalin pain test. Exp Neurol 1992;117:94.

173. Panerai AE et al. Antidepressants in cancer pain. J Palliat Care 1991;7:42.

174. Conn DK et al. Pattern of use of antidepressants in long-term care facilities for the elderly. J Geriatr Psychiatry Neurol 1992;5:228.

175. Goldstein DJ et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109.

176. Attal N. et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur Neurol 2006;13:1153.

177. Backonja M et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998;280:1831.

178. Rowbotham M et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837.

179. Dubinsky RM et al. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;63:959.

180. Smith AL et al. Cerebral blood flow and metabolism: effects of anesthetic drugs and techniques. Anesthesiology 1972;36:378.

181. Albanese J et al. Sufentanil increases intracranial pressure in patients with head trauma. Anesthesiology 1993;79:493.

182. Vandam LD. Drug therapy: butorphanol. N Engl J Med 1980;302:381.

183. Scott DH et al. Haemodynamic changes following buprenorphine and morphine. Anaesthesia 1980;35:957.

184. Gaensler EA et al. A comparative study of the action of Demerol and opium alkaloids in relation to biliary spasm. Surgery 1948;23:211.

185. Chisholm RJ et al. Narcotics and spasm of the sphincter of Oddi. A retrospective study of operative cholangiograms. Anaesthesia 1983;38:689.

P.8p36

186. Radnay PA et al. Common bile duct pressure changes after fentanyl, morphine, meperidine, butorphanol, and naloxone. Anesth Analg 1984; 63:441.

187. Radnay PA et al. The effect of equi-analgesic doses of fentanyl, morphine, meperidine and pentazocine on common bile duct pressure. Anaesthesist 1980;29:26.

188. Staritz M et al. Effect of modern analgesic drugs (tramadol, pentazocine, and buprenorphine) on the bile duct sphincter in man. Gut 1986;27:567.

189. Economou G et al. A cross-over comparison of the effect of morphine, pethidine, pentazocine, and phenazocine on biliary pressure. Gut 1971; 12:216.

190. Hopton DS et al. Action of various new analgesic drugs on the human common bile duct. Gut 1967;8:296.

191. McCammon RL et al. Reversal of fentanyl induced spasm of the sphincter of Oddi. Surg Gynecol Obstet 1983;156:329.

192. McCammon RL et al. Naloxone reversal of choledochoduodenal sphincter spasm associated with narcotic administration. Anesthesiology 1978;48:437.

193. McLean ER Jr et al. Cholangiographic demonstration of relief of narcotic-induced spasm of the sphincter of Oddi. Am Surg 1982;48:134.

194. Sykes NP. Oral naloxone in opioid-associated constipation [Letter]. Lancet 1991;337:1475.

195. Larsen LS et al. The use of intravenous ketorolac for the treatment of renal colic in the emergency department. Am J Emerg Med 1993;11:197.

196. Hoyampa AM Jr et al. The disposition and effects of sedatives and analgesics in liver disease. Ann Rev Med 1978;29:205.

197. Klotz U et al. The effect of cirrhosis on the disposition and elimination of meperidine in man. Clin Pharmacol Ther 1974;16:667.

198. Roberts RK et al. Drug prescribing in hepatobiliary disease. Drugs 1979;17:198.

199. Pond SM et al. Enhanced bioavailability of pethidine and pentazocine in patients with cirrhosis of the liver. Aust NZ J Med 1980;10:515.

200. Lehmann KA et al. CO₂-response curves as a measure of opiate-induced respiratory depression. Studies with fentanyl. Anaesthesist 1983;32:242.

201. Gal TJ et al. Analgesic and respiratory depressant activity of nalbuphine: a comparison with morphine. Anesthesiology 1982;57:367.

202. Nagashima H et al. Respiratory and circulatory effects of intravenous butorphanol and morphine. Clin Pharmacol Ther 1976;19:738.

203. Heel RC et al. Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs 1979;17:81.

204. Bailey CJ et al. Epidural morphine infusion. Continuous pain relief. AORN J 1984;39:997.

205. Jones SF, White A. Analgesia following femoral neck surgery. Lateral cutaneous nerve block as an alternative to narcotics in the elderly. Anaesthesia 1985;40:682.

206. Ostermeier et al. Three sudden postoperative respiratory arrests associated with epidural opioids in patients with sleep apnea. Anesth Analg1997;2:452.

207. Jain SS et al. Perioperative treatment of patients with obstructive sleep apnea. Curr Opin Pulm Med 2004;10:482.

208. American Geriatrics Society Panel on Chronic Pain in Older Persons. Clinical practice guidelines: the management of chronic pain in older persons. J Am Geriatr Soc 1998;46:635.

209. Won A et al. Correlates and management of nonmalignant pain in the nursing home. J Am Geriatr Soc 1999;47:936.

210. Fox PL et al. Prevalence and treatment of pain in older adults in nursing homes and other long-term care institutions: a systematic review. Can Med Assoc J 1999;160:329.

211. Faherty BS et al. Analgesic medication for elderly people post-surgery. Nurs Res 1984;33:369.

212. McCaffery M. Narcotic analgesia for the elderly. Am J Nurs 1985;85:296.

213. Cohen JL. Pharmacokinetic changes in aging. Am J Med 1986;80:31.

214. Ouslander JG. Drug therapy in the elderly. Ann Intern Med 1981;95:711.

215. Harkins SW et al. Pain and the elderly. Adv Pain Res Ther 1984;7:103.

216. Beyer JE et al. The assessment of pain in children. Pediatr Clin N Am 1989;36:837.

217. LaFleur CJ et al. School-age child and adolescent perception of the pain intensity associated with three word descriptors. Pediatric Nursing 1999;25:45.

218. Anand KJS et al. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. N Engl J Med 1992;326:1.

219. Olkkola KT et al. Kinetics and dynamics of postoperative intravenous morphine in children. Clin Pharmacol Ther 1988;44:128.

220. Gutner LB et al. The effects of potent analgesics upon vestibular function. J Clin Invest 1952; 31:259.

221. Dixon R et al. Levorphanol: pharmacokinetics and steady-state plasma concentrations in patients with pain. Res Commun Chem Pathol Pharmacol 1983;41:3.

222. Forrest WH et al. Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med 1977;296:712.

223. Twycross RG et al. Long-term use of morphine in advanced cancer. Adv Pain Res Ther 1976;1:653.

224. Webb SS et al. Toward the development of a potent, nonsedating, oral analgesic. Psychopharmacol 1978;60:25.

225. Yee JD et al. Dextroamphetamine or methylphenidate as adjuvants to opioid analgesia for adolescents with cancer. J Pain Symptom Manage 1994;9:122.

226. Tong TG et al. Phenytoin-induced methadone withdrawal. Ann Intern Med 1981;94:349.

227. Bernard SA et al. Drug interactions in palliative care. J Clin Oncol 2000;18:1780.

228. Sorkin EM et al. Cimetidine potentiation of narcotic action. Drug Intelligence and Clinical Pharmacy 1983;17:60.

229. Poulsen L et al. The hypoalgesic effect of tramadol in relation to CYP2D6. Clin Pharmacol Ther 1996;60:636.

230. Egberts AC, et al. Serotonin syndrome attributed to tramadol addition to paroxetine therapy. Int Clin Psychopharmacol 1997;12:181.

231. Caufriez A. Menstrual disorders in adolescence: pathophysiology and treatment. Horm Res 1991;36:156.

232. Mackinnon GL et al. Current concepts in the management of primary dysmenorrhea. Can Pharm J 1982;1150:3.

233. Mehlisch DR. Double-blind crossover comparison of ketoprofen, naproxen, and placebo in patients with primary dysmenorrhea. Clin Ther 1990;12:398.

234. Shapiro SS et al. The effect of ibuprofen in the treatment of dysmenorrhea. Curr Ther Res Clin Exp 1981;30:327.

235. Laska E et al. Caffeine as an analgesic adjuvant. JAMA 1984;251:1711.

236. Migliardi J et al. Caffeine as an analgesic adjuvant in tension headache. Clin Pharm Ther 1994;56:576.

237. Harden RN et al. Ketorolac in acute headache management. Headache 1991;31:463.

238. Roberts JE et al. Improved peribulbar anaesthesia with alkalinization and hyaluronidase. Can J Anaesth 1993;40:835.

239. Smith SL et al. The importance of bicarbonate in large volume anesthetic preparations. Revisiting the tumescent formula. J Dermatol Surg Oncol 1992;18:973.

240. Benini F et al. Topical anesthesia during circumcision in newborn infants. JAMA 1993;270:850.

241. Young SS et al. EMLA cream as a topical anesthetic before office phlebotomy in children. South Med J 1996;89:1184.

242. Farrington E. Lidocaine 2.5%/prilocaine 2.5% EMLA cream. Pediatric Nursing 1993;19:484.

243. Gershon RY et al. Intradermal anesthesia and comparison of intravenous catheter gauge. Anesth Analg 1991;73:469.

Posted in: Pain and Its Management